Diindolylmethane attenuates cardiomyocyte hypoxia by modulating autophagy in H 9 c 2 cells
Wen-hao Qian,K. Liang,Jing Zong
Abstract:Autophagy is activated in the ischemic heart and is a process that is essential for survival, differentiation, development and homeostasis. 3,3'-Diindolylmethane (DIM) is a natural product of the acid-catalyzed condensation of indole-3-carbinol in cruciferous vegetables. Numerous studies have suggested that DIM has various pharmacological effects, including antioxidant, antitumor, anti-angiogenic and anti-apoptotic properties. However, the function of DIM on hypoxia-induced cardiac injury remains to be elucidated. In the present study, H9c2 cells were pretreated with DIM (1, 5 and 10 μM) for 12 h and exposed to hypoxia for 12 h. It was demonstrated that DIM markedly attenuated the increased transcription of interleukin (IL)-1β, IL-6 and tumor necrosis factor-α induced by hypoxia. In addition, the transcription of autophagy associated genes increased in the DIM pretreated group, compared with the hypoxia group. DIM additionally attenuated the increased apoptosis, as determined by terminal deoxynucleotidyl transferase dUTP nick end labeling staining, and regulated the relative protein expression level of B cell lymphoma (Bcl) 2 associated X protein, Bcl-xL and cleaved caspase 3. Furthermore, the phosphorylation of the 5' AMP-activated protein kinase a (AMPKa) was activated and the phosphorylation of c-Jun N-terminal kinase (JNK) was inhibited. The effect of DIM on hypoxia-induced apoptosis was abolished following pretreatment with JNK activator (anisomycin, 40 ng/ml). The effect of DIM on autophagy was reversed following pretreatment with AMPKa inhibitor (CpC, 20 μM) following stimulation with hypoxia. The results demonstrated that DIM prevented hypoxia‐induced inflammation and apoptosis and activated cardiomyocyte autophagy, which may be mediated by activation of AMPKa and inhibition of JNK pathways. Introduction Ischemic heart disease (IHD) is the main cause of death and disability in the world. The incidence of acute myocardial infarction (MI), a consequence of an imbalance between oxygen supply and demand, is growing in the global burden of IHD (1). Autophagy is a highly conserved intracellular degradation process that is an adaptive role to protect organisms against diverse pathologies, including infections, cancer, aging, and heart disease (2). Recent studies have showed that cardiomyocytes autophagy was activated in ischemic heart disease (3). The increase of autophagy is associated with the protective effect of ischemic preconditioning (4). However, the mechanistic process remains to be fully elucidated between myocardial ischemia and autophagy. Hence, cardiomyocytes autophagy may be a promising approach for the prevention of myocardial ischemia and progression to heart failure. 3,3'-Diindolylmethane (DIM) is extracted from natural product, derived from the acid-catalyzed condensation of indole-3-carbinol in cruciferous vegetables. Numerous studies have suggested that DIM has various pharmacological effects, including antioxidant, antitumor, anti‐angiogenic, anti‐inflammatory and anti-apoptotic (5-8). Meanwhile DIM could affect AMPKα and JNK signaling pathway (9,10). DIM could inhibit the proliferation of cancer cells through modulating autophagy (11). The previous studies showed that DIM attenuated TGFβ1-induced myofibroblast differentiation through down-regulated AKT/GSK-3β signaling pathways (12). The cardioprotective effects of DIM on cardiac hypertrophy are partly mediated through AMPKa signaling (13). It also improved myocardial energy metabolism imbalance induced by pressure overload via AMPKα in mice (14). All these studies indicate the protective effect of DIM on cardiovascular disease. However, it remains unknow whether DIM would protect cardiomyocyte from hypoxia injury. The purpose of the study was to evaluate the effect of DIM on hypoxia injury in cardiomyocytes and the underlying mechanism. Materials and methods Materials. The primary antibodies included phosphorylated (p)-AMPKα (sc101631; Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA), T-AMPKα (BS4046, BS1061, BS6271, respectively; Bioworld Technology Inc., St. Louis Park, 3,3'‐Diindolylmethane attenuates cardiomyocyte hypoxia by modulating autophagy in H9c2 cells KAI LIANG1,2, WEN-HAO QIAN1,2 and JING ZONG1,2 1Institute of Cardiovascular Disease Research, Xuzhou Medical University; 2Department of Cardiology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu 221002, P.R. China Received December 2, 2016; Accepted June 1, 2017 DOI: 10.3892/mmr.2017.7788 Correspondence to: Mr. Wen-Hao Qian, Department of Cardiology, The Affiliated Hospital of Xuzhou Medical University, 99 West Huaihai Road, Xuzhou, Jiangsu 221002, P.R. China E-mail: DR63263907@163.com
Environmental Science,Medicine